HRP20110861T1 - Lijek za liječenje gripe - Google Patents

Lijek za liječenje gripe Download PDF

Info

Publication number
HRP20110861T1
HRP20110861T1 HR20110861T HRP20110861T HRP20110861T1 HR P20110861 T1 HRP20110861 T1 HR P20110861T1 HR 20110861 T HR20110861 T HR 20110861T HR P20110861 T HRP20110861 T HR P20110861T HR P20110861 T1 HRP20110861 T1 HR P20110861T1
Authority
HR
Croatia
Prior art keywords
enopyranozoic
tetradeoxy
galacto
glycero
guanidino
Prior art date
Application number
HR20110861T
Other languages
English (en)
Croatian (hr)
Inventor
Yamashita Makoto
Kawaoka Yoshihiro
Original Assignee
Daiichi Sankyo Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company filed Critical Daiichi Sankyo Company
Publication of HRP20110861T1 publication Critical patent/HRP20110861T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HR20110861T 2007-03-07 2011-11-21 Lijek za liječenje gripe HRP20110861T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007056872 2007-03-07
PCT/JP2008/053738 WO2008108323A1 (ja) 2007-03-07 2008-03-03 インフルエンザ治療剤

Publications (1)

Publication Number Publication Date
HRP20110861T1 true HRP20110861T1 (hr) 2011-12-31

Family

ID=39738201

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110861T HRP20110861T1 (hr) 2007-03-07 2011-11-21 Lijek za liječenje gripe

Country Status (17)

Country Link
US (2) US20100204314A1 (de)
EP (1) EP2123271B1 (de)
JP (2) JP5286251B2 (de)
KR (1) KR101473028B1 (de)
CN (1) CN101715343B (de)
AT (1) ATE526960T1 (de)
CA (1) CA2680415A1 (de)
CY (1) CY1112201T1 (de)
DK (1) DK2123271T3 (de)
ES (1) ES2372996T3 (de)
HK (1) HK1137142A1 (de)
HR (1) HRP20110861T1 (de)
PL (1) PL2123271T3 (de)
PT (1) PT2123271E (de)
SI (1) SI2123271T1 (de)
TW (1) TWI424841B (de)
WO (1) WO2008108323A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
JP5947289B2 (ja) 2010-05-10 2016-07-06 アカデミア シニカAcademia Sinica 抗インフルエンザ活性を有するザナミビルホスホネート同族体およびインフルエンザウイルスのオセルタミビルに対する感受性の決定
EP2960237A1 (de) * 2011-12-16 2015-12-30 Daiichi Sankyo Company, Limited Verfahren zur herstellung von neuraminsäurederivaten
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
CA2880701A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
KR102298172B1 (ko) 2013-09-06 2021-09-06 아카데미아 시니카 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015109180A2 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
EP3129767B1 (de) 2014-03-27 2021-09-01 Academia Sinica Reaktive markierungsverbindungen und ihre verwendungen
CN107074945B (zh) 2014-05-27 2021-08-24 中央研究院 增进抗体功效的通用糖型的组合物及方法
CA2950415A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2015184002A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-her2 glycoantibodies and uses thereof
WO2015184001A1 (en) 2014-05-28 2015-12-03 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
JP6779887B2 (ja) 2015-01-24 2020-11-04 アカデミア シニカAcademia Sinica 新規なグリカンコンジュゲートおよびその使用方法
WO2017156192A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3209946B2 (ja) * 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
DE69709795T2 (de) * 1996-07-22 2002-09-26 Sankyo Co Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung
US6451766B1 (en) * 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP4151800B2 (ja) 1996-08-13 2008-09-17 第一三共株式会社 ノイラミン酸化合物
JP3920041B2 (ja) * 2000-04-25 2007-05-30 三共株式会社 ノイラミン酸化合物の水和物及び結晶
TWI291462B (en) * 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
DE602006003600D1 (de) 2005-08-22 2008-12-24 Delphi Tech Inc Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad

Also Published As

Publication number Publication date
CN101715343B (zh) 2012-09-26
CA2680415A1 (en) 2008-09-12
DK2123271T3 (da) 2012-01-23
HK1137142A1 (en) 2010-07-23
EP2123271A4 (de) 2010-03-17
EP2123271B1 (de) 2011-10-05
US20140018418A1 (en) 2014-01-16
JPWO2008108323A1 (ja) 2010-06-17
CY1112201T1 (el) 2015-12-09
TWI424841B (zh) 2014-02-01
ES2372996T3 (es) 2012-01-30
CN101715343A (zh) 2010-05-26
EP2123271A1 (de) 2009-11-25
KR20090129414A (ko) 2009-12-16
ATE526960T1 (de) 2011-10-15
JP5286251B2 (ja) 2013-09-11
WO2008108323A1 (ja) 2008-09-12
PT2123271E (pt) 2011-12-20
JP2013139483A (ja) 2013-07-18
TW200848018A (en) 2008-12-16
KR101473028B1 (ko) 2014-12-15
JP6012076B2 (ja) 2016-10-25
SI2123271T1 (sl) 2012-05-31
PL2123271T3 (pl) 2012-03-30
US20100204314A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
HRP20110861T1 (hr) Lijek za liječenje gripe
RS53236B (en) BETA-AMYLOIDOSIS PEPTIDES
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
RS53124B (en) USE OF BETANECOL FOR THE TREATMENT OF XEROSOMOMY
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
ATE386534T1 (de) Orale darreichungsform enthaltend probiotische bakterien
EA201200631A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
CL2007002346A1 (es) Compuestos no nucleosidicos derivados de fenoxi-fenil sustituidos, inhibidores de la transcriptasa inversa del vih; composicion farmaceutica; y su uso para tratar prevenir una infeccion vih o para tratar el sida o crs.
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
ATE534378T1 (de) Titrierung von tapentadol
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
RS54158B1 (en) AMILOID BINDING AGENTS
BRPI0815920A2 (pt) Composto, composição farmacêutica, e, uso do composto.
MX2010001849A (es) Depsipeptidos ciclicos.
CY1116840T1 (el) Χρηση 24-norudca
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
RS52620B (en) THE USE OF CHITOSAN FOR THE TREATMENT OF INFLAMMATORY DISEASES OF NAILS